ClinicalTrials.Veeva

Menu

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

H

Hainan Medical University

Status and phase

Unknown
Phase 4

Conditions

Sepsis

Treatments

Drug: albumin

Study type

Interventional

Funder types

Other

Identifiers

NCT03153306
HannanPH

Details and patient eligibility

About

Correction of hypovolemia is an important therapeutic measure,Even though there is no consensus regarding infusion rates, a plasma volume (PV) expander is often given at a fast rate to treat a suspected hypovolemia without delay which can be associated with aggravation of adverse interstitial accumulation of macromolecules and fluid, especially in inflammatory conditions such as sepsis.the smallest possible volumes for PV resuscitation to maintain normovolemia should be used to reduce the risk of simultaneous interstitial fluid accumulation. The investigators tested the hypothesis that a slow infusion rate of a PV expander results in better plasma expansion than a fast infusion rate to patients with severe sepsis or septic shock.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • admitted to the ICU patients with severe sepsis or septic shock (diagnosis according to the 2012 surviving sepsis campaign guidelines)
  • there is low blood pressure (SBP < 90 or mean arterial pressure(MAP) < 65 or the systolic blood pressure is decreased 40 mmHg more than the basic level) or lactic acid or greater for 4 mmol/l
  • the informed consent

Exclusion criteria

  • less than 18 years of age
  • more than 80 years old
  • pregnant women
  • albumin allergies
  • the dying patients expected lifetime no more than 24 hours)
  • patient with myocardial infarction, heart failure
  • liver failure
  • refused to sign the informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

the "bolus" group
Experimental group
Description:
10ml/kg of the natural colloid 5% albumin was given at 1 hrs.
Treatment:
Drug: albumin
the"continuous" group
Experimental group
Description:
10ml/kg of the natural colloid 5% albumin was given over 6 hrs
Treatment:
Drug: albumin

Trial contacts and locations

1

Loading...

Central trial contact

rui li, PhD Candidate

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems